Venus Remedies secures in-licensing rights from Infex Therapeutics to develop and commercialize MET-X in India
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies
Offers affordable, high-quality solutions for diabetes care
Modi remarked that more than 20 illustrious research institutions such as IISc, IITs, CSIR and DBT-BRIC have played a major role in this research
Data from IDSP does not indicate any unusual rise in ILI/SARI cases anywhere in the country
The President said that there is a need to spread more and more awareness regarding the causes, diagnosis and treatment of cancer
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
The conference aims to bring various stakeholders and experts in the field of healthcare and digital solutions for ensuring ‘universal access to affordable and quality healthcare’
Monkeypox infections are usually self-limiting lasting between 2-4 weeks and patients generally recover with supportive management
Integrated Disease Surveillance Programme (IDSP) strengthened to improve disease surveillance and rapid data reporting
Subscribe To Our Newsletter & Stay Updated